| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/12/2009 | US20090068159 Insecticidal Compositions and Methods for Making Insect-Resistant Transgenic Plants |
| 03/12/2009 | US20090068157 Derivation of unlimited quantities of neutrophils on monocyte/dendritic cells |
| 03/12/2009 | US20090068148 Peptides of cav2.2 that inhibit pain |
| 03/12/2009 | US20090068139 LOOP PEPTIDE AND TGF alpha FOR STIMULATING STEM CELL PROLIFERATION AND MIGRATION |
| 03/12/2009 | US20090068121 Lantibiotics and uses thereof |
| 03/12/2009 | US20090068106 selectively inhibit alpha v beta 3 integrin; used in the treatment of diseases associated with angiogenesis and cancer |
| 03/12/2009 | US20090068104 Substantially Homogeneous Bio-Affecting Material Having a Pre-Determined Ratio of Bioaffecting Component to Cell Targeting Component, the Method for Making Such a Material and the Method of its use |
| 03/12/2009 | US20090068097 Method for non-invasive detection and treatment of cerebral aneurysms |
| 03/12/2009 | US20090068095 Carbonic anhydrase ix (g250) anitbodies and methods of use thereof |
| 03/12/2009 | DE102007056231A1 Proteins comprising a Kunitz domain useful as protease inhibitors for therapeutic purposes |
| 03/12/2009 | CA2711425A1 Antimicrobial activity of bacteriocin-producing lactic acid bacteria |
| 03/12/2009 | CA2698638A1 Bioresorbable and biocompatible compounds for surgical use |
| 03/12/2009 | CA2698396A1 Interferon alpha2a modified by polyethylene glycol, the preparation and use thereof |
| 03/12/2009 | CA2698357A1 Deletions in domain ii of pseudomonas exotoxin a that reduce non-specific toxicity |
| 03/12/2009 | CA2698232A1 Detection of toxigenic strains of clostridium difficile |
| 03/12/2009 | CA2698173A1 Interferon alpha 2b modified by polyethylene glycol, the preparation and use thereof |
| 03/12/2009 | CA2698011A1 Porcine adeno-associated viruses |
| 03/12/2009 | CA2697957A1 Synthetic apolipoprotein e mimicking polypeptides and methods of use |
| 03/12/2009 | CA2697404A1 Method for purifying the factor viii and the von willebrand factor |
| 03/12/2009 | CA2695960A1 Vegfr-1/nrp-1 targeting peptides |
| 03/12/2009 | CA2690974A1 Bone morphogenetic protein (bmp)-binding domains of proteins of the repulsive guidance molecule (rgm) protein family and functional fragments thereof, and use of same |
| 03/11/2009 | EP2034030A2 Novel compositions and methods for cancer |
| 03/11/2009 | EP2034023A1 C-C CKR-5 ,CC-Chemikines receptor, derivatives thereof and their uses |
| 03/11/2009 | EP2034022A1 Leukotriene B4 binding soluble lipocalin receptor from ixodes ricinus |
| 03/11/2009 | EP2034020A1 Method for manufacturing a modified peptide |
| 03/11/2009 | EP2034012A1 Vaccine against viral rabbit hemorrhagic disease |
| 03/11/2009 | EP2033972A1 Screening method for candidate drugs |
| 03/11/2009 | EP2033971A1 Bone Morphogenetic Protein (BMP) binding domains of proteins of the Repulsive Guidance Molecule (RGM) protein family and functional fragments thereof and their application |
| 03/11/2009 | EP2033970A2 WNT-1 inducible genes |
| 03/11/2009 | EP2033969A1 Multi-block copolymers |
| 03/11/2009 | EP2033968A1 Target of rapamycin modulators of and use thereof |
| 03/11/2009 | EP2033967A1 Hepatitis B viral variants with reduced susceptibility to nucleoside analogs and uses thereof |
| 03/11/2009 | EP2033662A1 Transglutaminase mediated conjugation of peptides |
| 03/11/2009 | EP2033661A1 Methods of screening affinity marker libraries |
| 03/11/2009 | EP2033598A1 Calcium phosphate based delivery of growth and differentiation factors to compromised bone |
| 03/11/2009 | EP2033512A1 Model animal of dendritic cell immunoreceptor gene knockout disease |
| 03/11/2009 | EP2032992A1 Method for the selective determination of procalcitonin 1-116 for diagnostic purposes and antibodies and kits for carrying out such a method |
| 03/11/2009 | EP2032748A1 Serpine1 polymorphisms are predictive of response to activated protein c administration and risk of death |
| 03/11/2009 | EP2032705A2 Use of a plastid-lipid associated protein promoter (pap promoter) for heterologous gene expression |
| 03/11/2009 | EP2032704A2 Plants with modulated expression of nac transcription factors having enhanced yield-related traits and a method for making the same |
| 03/11/2009 | EP2032699A2 Inhibitors of hcap18/ll-37 for use in the treatment of breast cancer |
| 03/11/2009 | EP2032601A2 Peptides regulating the surface expression of the t cell receptor |
| 03/11/2009 | EP2032600A2 Erythropoietin compositions |
| 03/11/2009 | EP2032599A2 Genes regulating intracellular cholesterol trafficking as targets for treatment of cholesterol-related diseases |
| 03/11/2009 | EP2032598A2 Axmi-031, axmi-039, axmi-040 and axmi-049, a family of delta-endotoxin genes and methods for their use |
| 03/11/2009 | EP2032597A2 Fplr-1 inhibitors for use in diseases involving amyloid-induced inflammatory events (flipr and flipr-like) and immunecomplex-mediated diseases |
| 03/11/2009 | EP2032156A2 Compositions and methods for the delivery of oxygen |
| 03/11/2009 | EP2032150A1 Novel enterococcus and streptococcus strains and bacteriocins |
| 03/11/2009 | EP1957526A4 Molecules inhibition intercellular adhesion |
| 03/11/2009 | EP1691824B1 Proteins belonging to the bcl-2 family and fragments thereof, and their use in cancer patients |
| 03/11/2009 | EP1636593B1 Modulating the interaction between hgf beta chain and c-met |
| 03/11/2009 | EP1601698B1 Physiologically active polypeptide conjugate having prolonged in vivo half-life |
| 03/11/2009 | EP1578790B8 A novel gene osisap1 of rice confers tolerance to stresses and a method thereof |
| 03/11/2009 | EP1558638B1 P53 binding polypeptide |
| 03/11/2009 | EP1517919B1 Marked peptides having affinity for a phospholipid and uses |
| 03/11/2009 | EP1379550B1 A chimeric protein comprising non-toxic pseudomonas exotoxin a and type iv pilin sequences |
| 03/11/2009 | EP1305409B1 Renal regulatory elements and methods of use thereof |
| 03/11/2009 | EP1212618B1 Effect of steroids on nmda receptors depends on subunit composition |
| 03/11/2009 | EP1173567B1 Tribonectins |
| 03/11/2009 | EP1149162B1 Medicament for the treatment of c. pneumoniae infections |
| 03/11/2009 | EP1071763B1 Vaccine formulations comprising antiidiotypic antibodies which immunologically mimic group b streptococcal carbohydrates |
| 03/11/2009 | EP0977579B1 Gastrin receptor-avid peptide conjugates |
| 03/11/2009 | EP0741784B1 Ligand (act-4-l) to a receptor on the surface of activated cd4+ t-cells |
| 03/11/2009 | CN101384722A 疫苗组合物 Vaccine compositions |
| 03/11/2009 | CN101384719A Method for producing terpenes and MEP-transformed microorganisms therefore |
| 03/11/2009 | CN101384623A Process for the production of preformed conjugates of albumin and a therapeutic agent |
| 03/11/2009 | CN101384622A FGF2-binding peptides and uses thereof |
| 03/11/2009 | CN101384621A Methods for production of receptor and ligand isoforms |
| 03/11/2009 | CN101384620A method of improving efficacy of biological response-modifying proteins and the exemplary muteins |
| 03/11/2009 | CN101384619A Modulation of bone formation |
| 03/11/2009 | CN101384618A Peptide based inhibition of capcna interaction in cancer |
| 03/11/2009 | CN101384617A Multimeric complexes of antigens and an adjuvant |
| 03/11/2009 | CN101384616A Luminescent transgenic non human animals, progeny, cell derivatives and uses thereof |
| 03/11/2009 | CN101384615A Novel gene products from bacillus licheniformis forming or decomposing polyamino acids and improved biotechnological production methods based thereon |
| 03/11/2009 | CN101384614A Vegf-activated fas ligands |
| 03/11/2009 | CN101384613A Novel antimicrobial peptides and use thereof |
| 03/11/2009 | CN101384261A Method and composition for treating pain |
| 03/11/2009 | CN101381731A Method for obtaining 4 type hepatitis e virus recombinant polypeptides |
| 03/11/2009 | CN101381729A Sugarcane water stress relevant zinc finger protein shZFP1 gene order |
| 03/11/2009 | CN101381726A Method for expressing growth factor of human blood vessel in bombyx mori by Bac-to-Bac system |
| 03/11/2009 | CN101381411A Sipunculid collagen protein and preparation method thereof |
| 03/11/2009 | CN101381410A Rhodamine 123 artificial antigen synthesis, antibody preparation method and application |
| 03/11/2009 | CN101381409A N-terminally chemically modified protein compositions and methods |
| 03/11/2009 | CN101381408A Cobratide extraction method, cobratide extracted thereby and formulation containing cobratide |
| 03/11/2009 | CN101381407A Preparation and application of polypeptide medicine for treating mycobacterium tuberculosis infection |
| 03/11/2009 | CN101381406A Sword prawn allergen protein and preparation and application in medicine thereof |
| 03/11/2009 | CN101381405A Genetic engineering tumor targeting KCT-W1 polypeptides and preparation method and application |
| 03/11/2009 | CN101381404A Targeting tumor protein KCT-W2, preparation method and application |
| 03/11/2009 | CN100467605C Adenovirus-transfected primary cells and methods of pathway mapping |
| 03/11/2009 | CN100467604C Chimeric GFP-aequorin as bioluminescent ca<++> reporters at the single cell level |
| 03/11/2009 | CN100467600C Compounds and methods for treatment and diagnosis of chlamydial infection |
| 03/11/2009 | CN100467599C Bridsfoot trefoil pattern schema and anthotaxis structure regulating gene, encoding protein and use thereof |
| 03/11/2009 | CN100467598C Fungal cell wall synthesis gene |
| 03/11/2009 | CN100467597C Fungal cell wall synthesis gene |
| 03/11/2009 | CN100467490C Solid phase synthesis method of peptide-spacer-lipoid conjugate, synthesized conjugate and targeting liposome containing the conjugate |
| 03/11/2009 | CN100467489C Specific antibodies proBNP(1-108) for diagnosing heart failure |
| 03/11/2009 | CN100467488C Il-7 fusion proteins |
| 03/11/2009 | CN100467487C Multifunctional polypeptide |
| 03/11/2009 | CN100467486C Rice leaf inward-curl gene and its uses |
| 03/11/2009 | CN100467485C SARS coronary virus related polypeptide and its uses |